Physical and Cognitive Performance and Burden of Anticholinergics, Sedatives, and ACE Inhibitors in Older Women
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Polypharmacy, common in older people, confers both risk of adverse outcomes and benefits. We assessed the relationship of commonly prescribed medications with anticholinergic and sedative effects to physical and cognitive performance in older individuals. The study population comprised 932 moderately to severely disabled community-resident women aged 65 years or older who were participants in the Women's Health and Aging Study I. A scale based on pharmacodynamic principles was developed and utilized as a measure of drug burden. This was related to measures of physical and cognitive function. After adjusting for demographics and comorbidities, anticholinergic drug burden was independently associated with greater difficulty in four physical function domains with adjusted odds ratios (95% confidence interval (CI)) of 4.9 (2.0-12.0) for balance difficulty; 3.2 (1.5-6.9) for mobility difficulty; 3.6 (1.6-8.0) for slow gait; 4.2 (2.0-8.7) for chair stands difficulty; 2.4 (1.1-5.3) for weak grip strength; 2.7 (1.3-5.4) for upper extremity limitations; 3.4 (1.7-6.9) for difficulty in activities of daily living; and 2.4 (95% CI, 1.1-5.1) for poor performance on the Mini-Mental State Examination. Sedative burden was associated only with impaired grip strength (3.3 (1.5-7.3)) and mobility difficulty (2.4 (1.1-5.3)). The burden of multiple drugs can be quantified by incorporating the recommended dose regimen and the actual dose and frequency of drug taken. Anticholinergic drug burden is strongly associated with limitations in physical and cognitive function. Sedative burden is associated with impaired functioning in more limited domains. The risk associated with exposure of vulnerable older women to drugs with anticholinergic properties, and to a lesser extent those with sedative properties, implies that such drugs should not be used in this patient group without compelling clinical indication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Certain drugs, such as psychotropic and anticholinergic medications, can impair exercise through their effects on cognition, sedation, orthostasis, and mobility [[540], [541], [542], [543]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [542]
In the citing paper
“Certain medications, such as psychotropics and anticholinergics, can interference with exercise participation and physiological adaptation, necessitating adjustments to exercise prescriptions, behavioral interventions, and careful monitoring to ensure treatment efficacy [[540], [541], [542]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [542]
In the citing paper
“Certain drugs, such as psychotropic and anticholinergic medications, can impair exercise through their effects on cognition, sedation, orthostasis, and mobility [[540], [541], [542], [543]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [542]
In the citing paper
“Importantly, exercise can substitute for medications that impair cognitive function and mobility. Psychotropic medications (antipsychotics, anxiolytics, insomniacs, antidepressants), which can cause confusion, sedation and fatigue, may be replaced with aerobic or PRT, significantly enhancing a patient’s physical and cognitive health.”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [542]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability
Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Salive, M. E., & Wallace, R. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320902 · Cited by 4,083
Self-citationTinetti, M. E., Baker, D. I., McAvay, G., Claus, E. B., Garrett, P., Gottschalk, M., Koch, M. L., Trainor, K., & Horwitz, R. I. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409293311301 · Cited by 2,147 · cited 1×
“Ideally, effective disease treatment, including medication use, should reduce the rate of or prevent the progression of disease-associated disability.(15) Many medications have undesirable side effects, which negatively impact physical and cognitive function.”
BackgroundDrugs and Falls in Older People: A Systematic Review and Meta‐analysis: I. Psychotropic Drugs
Leipzig, R. M., Cumming, R. G., & Tinetti, M. E. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01898.x · Cited by 1,153
Psychotropic Drug Use and the Risk of Hip Fracture
Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K., & Melton, L. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160702 · Cited by 1,000
Prevalence and severity of cognitive impairment with and without dementia in an elderly population
Graham, J. E., Rockwood, K., Beattie, B. L., Eastwood, R., Gauthier, S., Tuokko, H., & McDowell, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01007-6 · Cited by 999
Disability in Older Adults: Evidence Regarding Significance, Etiology, and Risk
Fried, L. P., & Guralnik, J. M. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00986.x · Cited by 866
Self-citationCentral Nervous System–Active Medications and Risk for Falls in Older Women
Ensrud, K. E., Blackwell, T. L., Mangione, C. M., Bowman, P. J., Whooley, M. A., Bauer, D. C., Schwartz, A. V., Hanlon, J. T., Nevitt, M. C., & For The Study of Osteoporotic Fractures Research Group (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50453.x · Cited by 620
Kappa–opioids produce significantly greater analgesia in women than in men
Gear, R. W., Miaskowski, C., Gordon, N. C., Paul, S. M., Heller, P. H., & Levine, J. D. (1996) · Nature Medicine · doi:10.1038/nm1196-1248 · Cited by 457 · cited 1×
“There are reports of sex differences, for example, in ADL,(24) the pharmacokinetics of midazolam,(25) and the pharmacodynamics of opioids.(26,27) Therefore, these findings should not be generalized to men until the relationship between drug burden and function is studied in a population that includes men.”
BackgroundAssociation of Comorbidity with Disability in Older Women
Fried, L. P., Bandeen-Roche, K., Kasper, J. D., & Guralnik, J. M. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00124-3 · Cited by 454
Self-citationAssociation between falls in elderly women and chronic diseases and drug use: cross sectional study
Lawlor, D. A., Patel, & Ebrahim, S. (2003) · BMJ · doi:10.1136/bmj.327.7417.712 · Cited by 444
Risk Factors for Adverse Drug Events Among Older Adults in the Ambulatory Setting
Field, T. S., Gurwitz, J. H., Harrold, L. R., Rothschild, J., DeBellis, K. R., Seger, A. C., Auger, J. C., Garber, L. A., Cadoret, C., Fish, L. S., et al. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52367.x · Cited by 298
Simonsick, E. M., Guralnik, J. M., Volpato, S., Balfour, J., & Fried, L. P. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53103.x · Cited by 293
Self-citationAssociation of Anticholinergic Load With Impairment of Complex Attention and Memory in Schizophrenia
Minzenberg, M. J., Poole, J. H., Benton, C., & Vinogradov, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.116 · Cited by 283
Mulsant, B. H., Pollock, B. G., Kirshner, M., Shen, C., Dodge, H., & Ganguli, M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.198 · Cited by 279
Physical disability in older adults: A physiological approach
Fried, L. P., Ettinger, W. H., Lind, B., Newman, A. B., & Gardin, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90172-4 · Cited by 243
Self-citationDunlop, D. D., Manheim, L. M., Sohn, M.-W., Liu, X., & Chang, R. W. (2002) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2002.32817 · Cited by 215
Lechevallier‐Michel, N., Molimard, M., Dartigues, J., Fabrigoule, C., & Fourrier‐Réglat, A. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02232.x · Cited by 207
Polypharmacy: A New Paradigm for Quality Drug Therapy in the Elderly?
Gurwitz, J. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.18.1957 · Cited by 190
Benzodiazepine use and cognitive function among community-dwelling elderly*
Hanlon, J. T., Horner, R. D., Schmader, K. E., Fillenbaum, G. G., Lewis, I. K., Wall, W. E., Landerman, L. R., Pieper, C. F., Blazer, D. G., & Cohen, H. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90059-5 · Cited by 187
Predictors of combined cognitive and physical decline
Atkinson, H. H., Cesari, M., Kritchevsky, S. B., Penninx, B. W. J. H., Fried, L. P., Guralnik, J. M., & Williamson, J. D. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53362.x · Cited by 179
Self-citationAnticholinergic Drugs and Physical Function Among Frail Elderly Population
Landi, F., Russo, A., Liperoti, R., Cesari, M., Barillaro, C., Pahor, M., Bernabei, R., & Onder, G. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100035 · Cited by 176 · cited 1×
“This includes increased fall risk with psychotropic drug exposure and an association between anticholinergic drug exposure, impaired cognition, and impaired physical function.(20)”
BackgroundThe Relationship Between Number of Medications and Weight Loss or Impaired Balance in Older Adults
Agostini, J. V., Han, L., & Tinetti, M. E. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52467.x · Cited by 167
on behalf of investigators of the GIFA Study, Onder, G., Landi, F., Cesari, M., Gambassi, G., Carbonin, P., & Bernabei, R. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0600-8 · Cited by 152
Sarton, E., Teppema, L., & Dahan, A. (1999) · Anesthesiology · doi:10.1097/00000542-199905000-00017 · Cited by 121
MD, C. A. S., Liu, H., Gutierrez, P. R., Seeley, D. G., Cummings, S. R., & MD, C. M. M. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb03908.x · Cited by 117 · cited 1×
“Although causality cannot be assessed with a crosssectional design, changes in physical and cognitive function are clearly related to adverse clinical outcomes.(10,14,22,23) Thus, the findings reported here may be useful for physicians in assessing risk–benefit for drug treatments in geriatric practice (Figure 3 ).”
BackgroundSimonsick, E. M., Maffeo, C. E., Rogers, S. K., Skinner, E. A., Davis, D., Guralnik, J. M., Fried, L. P., & WHAS Research Group (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.5.m264 · Cited by 115
Self-citationSnipping the thread of life. Antimuscarinic side effects of medications in the elderly
Peters, N. L. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2414 · Cited by 82
Benzodiazepine Exposure and Functional Status in Older People
Ried, L. D., Johnson, R. E., & Gettman, D. A. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb01016.x · Cited by 66
Benzodiazepine Use and Physical Performance in Community‐Dwelling Older Women
Gray, S. L., Penninx, B. W. J. H., Blough, D. K., Artz, M. B., Guralnik, J. M., Wallace, R. B., Buchner, D. M., & LaCroix, A. Z. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51502.x · Cited by 63 · cited 1×
“Although causality cannot be assessed with a crosssectional design, changes in physical and cognitive function are clearly related to adverse clinical outcomes.(10,14,22,23) Thus, the findings reported here may be useful for physicians in assessing risk–benefit for drug treatments in geriatric practice (Figure 3 ).”
BackgroundLIVER BLOOD FLOW DURING HIGH FREQUENCY OSCILLATION AND CONVENTIONAL MECHANICAL VENTILATION
Mackenzie, C. F., Roberts, H. G., Takeda, J., Hoff, B. H., Johnston, G. S., Helrich, M., & Hill, J. L. (1984) · Anesthesiology · doi:10.1097/00000542-198409001-00027 · Cited by 43
Cited by
Fávaro-Moreira, N. C., Krausch-Hofmann, S., Matthys, C., Vereecken, C., Vanhauwaert, E., Declercq, A., Bekkering, G. E., & Duyck, J. (2016) · Advances in Nutrition · doi:10.3945/an.115.011254 · Cited by 625
Salahudeen, M. S., Duffull, S. B., & Nishtala, P. S. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0029-9 · Cited by 547
“Numerous studies have found an association between use of anticholinergic medicines and adverse outcomes related to physical function, cognition and falls in older people [2,4,29-31].”
BackgroundJyrkkä, J., Enlund, H., Lavikainen, P., Sulkava, R., & Hartikainen, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2116 · Cited by 417
“Besides the expected positive effects, drugs may also cause among others loss of appetite, sedation and different kind of limitations in physical and cognitive function.(10,34,35) This longitudinal study confirms the associations between polypharmacy (more specifically for those using 10 drugs or more) and nutrition,…”
ResultRuxton, K., Woodman, R. J., & Mangoni, A. A. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12617 · Cited by 360
The Effects of Polypharmacy in Older Adults
Hilmer, S., & Gnjidic, D. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.224 · Cited by 362
Self-citation
Metadata
- Authors
- Cao, Y.-J., Mager, D., Simonsick, E., Hilmer, S., Ling, S., Windham, B., Crentsil, V, Yasar, S., Fried, L., & Abernethy, D.
- Affiliations
- Johns Hopkins University (US)
- National Institute on Aging (US)
- Corresponding author
- Abernethy, DR
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-08-22
- Volume
- 83
- Issue
- 3
- Pages
- 422-429
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2001917448
- Cited by
- 188
- References
- 32
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 4 · 2021: 17 · 2020: 15 · 2019: 13 · 2018: 4 · 2017: 6 · 2016: 14 · 2015: 14 · 2014: 5 · 2013: 6 · 2012: 17
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health (5r37ag019905-10)
- National Institute on Aging (R01 AG-19825, R37-AG19905, N01AG12112, R01AG019825)
- National Institute of General Medical Sciences (T32GM066691)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Balance, Gait, and Falls Prevention
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- anticholinergic burden, ACE inhibitors, polypharmacy, older women, physical function, cognitive function, balance, mobility (physical function), grip strength, activities of daily living, Mini-Mental State Examination
- MeSH terms
- Aged, Aged, 80 and over, Angiotensin-Converting Enzyme Inhibitors, Cognition, Cognition Disorders, Cross-Sectional Studies, Female, Humans, Hypnotics and Sedatives, Movement, Residence Characteristics, Cholinergic Antagonists, Polypharmacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.